Publication Date

1-1-2021

Journal

Health Psychology Research

DOI

10.52965/001c.27241

PMID

34746493

PMCID

PMC8567798

PubMedCentral® Posted Date

8-6-2021

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes

Keywords

analgesics, opioids, chronic pain, buprenorphine

Abstract

With the ongoing public health crisis with prescription opioids, there is a need for safer alternatives for medication management in chronic pain patients. Buprenorphine is a partial mu-opioid agonist which is commonly utilized to treat patients with opioid-use disorders. The purpose of this review is to discuss the potential use of this medication for the treatment of chronic pain instead of resorting to more traditional Schedule II opioids. Buprenorphine offers a safer alternative for patients who require opioids to manage chronic pain, given the unique pharmacological properties that allow it to provide adequate analgesia with less abuse potential.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.